secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2023-03-03T23:59:59+00:00
Accession:  0001193125-23-059999
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Graybug Vision discloses supplemental merger details, CMO Parisa Zamiri terminated ahead of CalciMedica merger
--------------------------------------------------------------------------------

- CMO Parisa Zamiri terminated Feb 28, 2023; receives $829,084 severance, COBRA, and stock acceleration.
- Zamiri also signed consulting agreement at $350/hr up to 8 hrs/week through May 21, 2023.
- Supplemental disclosures include corrected CalciMedica financial projections (revenue starting FY2028) and Piper Sandler analysis.
- Piper Sandler to receive $3M fee for merger advisory; $100K retainer and $750K opinion fee already earned.
- Four stockholder lawsuits and nine demand letters allege proxy statement omissions; Graybug believes claims without merit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523059999/0001193125-23-059999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312523059999/d424298d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-059999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer